Aptar commences clinical study to accelerate FDA approval of SmartTrack
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The products will be manufactured in Goa India and marketed & distributed in Australian markets
Subscribe To Our Newsletter & Stay Updated